Why Is Verve Therapeutics (VERV) Stock Down 39% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Verve Therapeutics stock is falling on Monday even after the company posted promising interim data from a Phase 1b clinical trial.

The post Why Is Verve Therapeutics (VERV) Stock Down 39% Today? appeared first on InvestorPlace.

• ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors